Free tool
Stocks listed on Nasdaq GM
We cover 9 companies listed on Nasdaq GM. The median market value in the group is $2.74B. Across the group, the median move over the past trading day is 0.00%. Price change over the past year runs from +19.3% to +262.4% across the middle 80 percent of the group, with a median of +143.2%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
Table
9 of 701 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| APGE | Apogee Therapeutics, Inc. | $10.21B | Large cap | +257.11% |
| CNTA | Centessa Pharmaceuticals plc | $6.27B | Mid cap | +143.24% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.85B | Mid cap | +55.97% |
| ZLAB | Zai Lab Limited | $2.92B | Mid cap | −20.06% |
| ATAI | AtaiBeckley Inc. | $2.74B | Mid cap | +61.71% |
| CDNA | CareDx, Inc. | $2.64B | Mid cap | +283.45% |
| RAPP | Rapport Therapeutics, Inc. | $2.52B | Mid cap | +250.70% |
| ATRC | AtriCure, Inc. | $2.45B | Mid cap | +29.14% |
| XNCR | Xencor, Inc. Common Stock | $2.11B | Mid cap | +254.61% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.